|
The Keryx (Nasdaq: KERX) Media Blunder Will Add to Our 700% Gain
Money Morning On August 29, 2012, shares of Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX), a company focused on pharmaceutical products for patients with renal disease, closed for the day's session at .06. Exactly two years later, on August 29, 2014, the same … |